Retrospective Study
Copyright ©The Author(s) 2022.
World J Orthop. Mar 18, 2022; 13(3): 289-296
Published online Mar 18, 2022. doi: 10.5312/wjo.v13.i3.289
Table 1 Categorization of cases according to composite reference standard
Cases
Smear microscopy
Culture
Gene Xpert
ATT course (in mo)
Outcome (SF-12)
CRS category
PCS-12
MCS-12
Case No. 1NegativeNo growthPositive12 48.7655.50Probable OATB case
Case No. 2NegativePositivePositiveLost to follow-upConfirmed OATB case
Case No. 3NegativeNo growthPositive15 46.0356.9Probable OATB case
Case No. 4NegativeNo growthPositiveLost to follow-upProbable OATB case
Case No. 5NegativeNo growthPositiveLost to follow-upProbable OATB case
Case No. 6PositiveNo growthPositiveLost to follow-upProbable OATB case
Case No. 7NegativeNo growthPositive2456.5760.75Probable OATB case
Case No. 8NegativeNo growthPositive2446.0356.9Probable OATB case
Case No. 9NegativeNo growthPositive6 48.6033.57Probable OATB case
Case No. 10PositiveNo growthPositiveLost to follow-upProbable OATB case
Case No. 11NegativeNo growthPositiveLost to follow-upProbable OATB case
Case No. 12NegativeNo growthPositiveLost to follow-upProbable OATB case
Case No. 13NegativeNo growthPositiveLost to follow-upProbable OATB case
Case No. 14PositiveNo growthPositiveLost to follow-upProbable OATB case
Case No. 15PositiveContaminationPositiveLost to follow-upProbable OATB case
Case No. 16NegativeContaminationPositiveLost to follow-upProbable OATB case
Case No. 17NegativeNo growthPositive6 56.5760.75Probable OATB case
Case No. 18NegativeNo growthPositiveLost to follow-upProbable OATB case
Case No. 19NegativeNo growthPositive6 52.2356.51Probable OATB case
Case No. 20NegativeNo growthPositive21 52.2356.51Probable OATB case
Case No. 21NegativeNo growthPositive1552.2353.63Probable OATB case
Case No. 22PositiveContaminationPositive1256.5760.75Probable OATB case
Case No. 23NegativeNo growthPositive1548.6033.57Probable OATB case
Case No. 24NegativeNo growthPositiveLost to follow-upProbable OATB case
Case No. 25PositivePositivePositiveLost to follow-upConfirmed OATB case
Case No. 26NegativeNo growthPositive1251.8148.67Probable OATB case
Case No. 27NegativePositivePositive1248.7655.50Confirmed OATB case
Case No. 28NegativeNo growthPositive6 56.5760.75Probable OATB case
Case No. 29NegativeNo growthPositiveLost to follow-upProbable OATB case
Case No. 30NegativeNo growthPositive1251.8148.67Probable OATB case
Case No. 31NegativeNo growthPositiveLost to follow-upProbable OATB case
Case No. 32NegativeNo growthPositive1240.7640.94Probable OATB case
Case No. 33NegativeNo growthPositiveLost to follow-upProbable OATB case
Case No. 34NegativePositivePositive228.9340.32Confirmed OATB case
Case No. 35NegativeNo growthPositive1.5 28.9340.32Probable OATB case
Case No. 36NegativePositiveNegative1248.7655.50Confirmed OATB case
Case No. 37NegativeNo growthNegative1.5 28.9340.32Possible OATB case
Table 2 Demographic and clinical distribution of composite reference standard positive, probable and possible osteoarticular tuberculosis cases, n (%)
Characteristics
Cases (n = 37)
Age group (yr)0 - 101 (2.7)
11 - 205 (13.6)
21 – 3010 (27.0)
31 - 406 (16.2)
41- 506 (16.2)
51 - 606 (16.2)
> 603 (8.1)
SexMale19 (51.4)
Female18 (48.6)
Site if OATBKnee8 (21.6)
Spine20 (54.1)
Elbow1 (2.7)
Wrist1 (2.7)
Psoas abscess7 (18.9)
Table 3 Performance assay and statistical analysis of gene Xpert, culture and, smear microscopy against composite reference standard (n = 40)
Methods
Sensitivity (%)
Specificity (%)
PPV (%)
NPV (%)
Kappa statistics (% agreement)
Gene Xpert94.6100.094.6100.095.0
Culture13.5100.013.5100.020.0
Smear microscopy16.2100.016.2100.022.5